PAR 1.67% 30.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4231

  1. 756 Posts.
    lightbulb Created with Sketch. 139
    My estimate would be enrolment concluded by the end of calendar year 2025. Another 1 year to get to 404 day data point. 6 months to collate data. 1 further year to get FDA approval. So I'm expecting 1st iPPS sales in USA in around mid-2028, everything goes relatively smoothly.

    It'll be interesting what TGA does, with some FDA guidance appearing to already have been received by PR and co.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.005(1.67%)
Mkt cap ! $106.6M
Open High Low Value Volume
30.5¢ 31.5¢ 29.5¢ $152.7K 501.9K

Buyers (Bids)

No. Vol. Price($)
2 16864 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 20426 2
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.